Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Tel Aviv, Israel
Countries of investment
  • Israel
Investment stages
  • Series B
  • Series C
Industries
    About
    Corundum Neuroscience is a company dedicated to propelling breakthroughs in neuroscience from lab to life. They support cutting-edge neuroscience research and build and fund ambitious companies to bring life-changing solutions to market.
    Min check size
    $250K
    Max check size
    $5M
    Fund size
    NPS

    Investment Thesis

    Focuses on investing in startups that are developing groundbreaking consumer and enterprise technologies.
    Lead investor
    Co Invest
    Number of exits
    Preferred contact method

    Manager's Experience

    With extensive experience in venture capital, the fund manager has actively participated in over 50 deals across technology and healthcare sectors, primarily in North America and Europe. They emphasize a thematic investment approach, focusing on emerging technologies that enhance user experience and operational efficiency. Notable exits have included successful acquisitions by leading industry players, showcasing their strategic foresight and operator-first mindset. Their expertise in early-stage investments allows them to identify and support innovative startups poised for significant growth.

    Joy Ventures Contacts Information

    Primary contact

    Secondary contact

    Team

    Miri Loven

    Cilla Zack

    Idan Katz

    Fund number
    Vintage Year
    Net Internal Rate of Return
    Investment Multiple
    Capital Allocation
    Management Fee
    Carried Interest
    AUM
    Follow-on Investments
    Graduation Rate
    Write-Off Ratio
    Last profile update timestamp